Clinical Trial Update: The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the efficacy and safety of Guilu Erxian Jiao for intradialytic hypotension in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Intradialytic Hypotension

Drugs mentioned

• Guilu Erxian Jiao

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Intradialytic Hypotension, End-Stage Renal Disease | Phase 2 | Status: NOT_YET_RECRUITING